Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Factor Therapeutics

Factor Therapeutics
PUBLIC STATUS
FTT STOCK SYMBOL
Description

Factor Therapeutics Ltd is a biotechnology company. It is engaged in the development and commercialisation of the Company's proprietary intellectual property in wound healing and tissue regeneration.

Formerly Known As
Tissue Therapies
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
ASX
Primary Office
  • Brisbane, Ontario
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Factor Therapeutics’s full profile, request a free trial.

Factor Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.48M 5.2M 1.04B

Factor Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
30-Jun-2017
FY 2016
30-Jun-2016
Enterprise Value 2,114 (664) 29,390 7,656
EBITDA (8,181) (4,245) (8,500)
Net Income (8,178) (4,216) (8,458)
Total Assets 1,956 8,590 12,282
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Factor Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Christian Behrenbruch Ph.D Executive Director